Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone plus atorvastatin versus atorvastatin alone for carotid intima-media thickness
2004-004463-30Phase 2Completed
- Sponsor
- Takeda
- Start
- Apr 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of pioglitazone and atorvastatin in atherosclerosis, hypercholesterolemia and cardiac morbidity (2 arms), sponsored by Takeda. Primary endpoint: Change in carotid intima-media thickness after 24 weeks. Started Apr 2005; status: completed.
02
Drugs
pioglitazoneatorvastatin
03
Conditions
atherosclerosishypercholesterolemiacardiac morbidity
Beyond the preview
Go deeper on 2004-004463-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-004463-30.